BioNTech SEBNTXNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-66.8%
5Y CAGR-34.2%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-66.8%/yr
Annual compound
5Y CAGR
-34.2%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 7.41% |
| 2023 | 3.05% |
| 2022 | 65.40% |
| 2021 | 201.57% |
| 2020 | 150.58% |
| 2019 | 59.99% |
| 2018 | -8.23% |
| 2017 | 0.00% |
| 2016 | 0.00% |